|
RFWD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.680000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.917600E-02 |
| Normal-vs-Stage2 |
9.807800E-01 |
| Normal-vs-Stage3 |
5.502000E-02 |
| Normal-vs-Stage4 |
8.588600E-01 |
| Stage1-vs-Stage2 |
3.871800E-01 |
| Stage1-vs-Stage3 |
8.844900E-03 |
| Stage1-vs-Stage4 |
3.819600E-01 |
| Stage2-vs-Stage3 |
1.299640E-01 |
| Stage2-vs-Stage4 |
8.521600E-01 |
| Stage3-vs-Stage4 |
3.309600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.787200E-01 |
| Normal-vs-AfricanAmerican |
1.092200E-01 |
| Normal-vs-Asian |
4.866800E-01 |
| Caucasian-vs-AfricanAmerican |
5.356200E-02 |
| Caucasian-vs-Asian |
7.625000E-01 |
| AfricanAmerican-vs-Asian |
2.751600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.993000E-01 |
| Normal-vs-Female |
1.382180E-01 |
| Male-vs-Female |
2.967600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.561190E-01 |
| Normal-vs-Extreme_Weight |
1.005410E-01 |
| Normal-vs-Obese |
3.152600E-01 |
| Normal-vs-Extreme_Obese |
7.590000E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.646000E-01 |
| Normal_Weight-vs-Obese |
5.018300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.132600E-01 |
| Extreme_Weight-vs-Obese |
2.848500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.049600E-01 |
| Obese-vs-Extreme_Obese |
7.137700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.013800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.961600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.354200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.123300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.098000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.113170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.893600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.589500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.848000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.717000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.380600E-01 |
| Normal-VS-Type2 PRCC |
1.652810E-01 |
| Normal-VS-KIRP CIMP |
7.339700E-02 |
| Normal-VS-Unclassified PRCC |
1.500760E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.029780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.942100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.014430E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.442900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.503900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.956160E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.630600E-01 |
| Normal-vs-N1 |
6.242400E-03 |
| Normal-vs-N2 |
2.540000E-01 |
| N0-vs-N1 |
1.315990E-03 |
| N0-vs-N2 |
7.975600E-01 |
| N1-vs-N2 |
9.648000E-02 |
|
|
